Molecular Diagnostic Unit, Diagnostic Laboratories, Bristol Veterinary School and Langford Vets, University of Bristol, Langford, UK.
Department of Pathobiology and Population Sciences, The Royal Veterinary College, University of London, Hatfield, Hertfordshire, UK.
Parasit Vectors. 2018 Mar 20;11(1):184. doi: 10.1186/s13071-018-2717-8.
In the Mediterranean basin, Leishmania infantum is a major cause of disease in dogs, which are frequently co-infected with other vector-borne pathogens (VBP). However, the associations between dogs with clinical leishmaniosis (ClinL) and VBP co-infections have not been studied. We assessed the risk of VBP infections in dogs with ClinL and healthy controls.
We conducted a prospective case-control study of dogs with ClinL (positive qPCR and ELISA antibody for L. infantum on peripheral blood) and clinically healthy, ideally breed-, sex- and age-matched, control dogs (negative qPCR and ELISA antibody for L. infantum on peripheral blood) from Paphos, Cyprus. We obtained demographic data and all dogs underwent PCR on EDTA-blood extracted DNA for haemoplasma species, Ehrlichia/Anaplasma spp., Babesia spp., and Hepatozoon spp., with DNA sequencing to identify infecting species. We used logistic regression analysis and structural equation modelling (SEM) to evaluate the risk of VBP infections between ClinL cases and controls.
From the 50 enrolled dogs with ClinL, DNA was detected in 24 (48%) for Hepatozoon spp., 14 (28%) for Mycoplasma haemocanis, 6 (12%) for Ehrlichia canis and 2 (4%) for Anaplasma platys. In the 92 enrolled control dogs, DNA was detected in 41 (45%) for Hepatozoon spp., 18 (20%) for M. haemocanis, 1 (1%) for E. canis and 3 (3%) for A. platys. No Babesia spp. or "Candidatus Mycoplasma haematoparvum" DNA was detected in any dog. No statistical differences were found between the ClinL and controls regarding age, sex, breed, lifestyle and use of ectoparasitic prevention. A significant association between ClinL and E. canis infection (OR = 12.4, 95% CI: 1.5-106.0, P = 0.022) was found compared to controls by multivariate logistic regression. This association was confirmed using SEM, which further identified that younger dogs were more likely to be infected with each of Hepatozoon spp. and M. haemocanis, and dogs with Hepatozoon spp. were more likely to be co-infected with M. haemocanis.
Dogs with ClinL are at a higher risk of co-infection with E. canis than clinically healthy dogs. We recommend that dogs diagnosed with ClinL should be tested for E. canis co-infection using PCR.
在地中海盆地,利什曼原虫是犬类疾病的主要病因,犬类常同时感染其他媒介传播病原体(VBP)。然而,患有临床利什曼病(ClinL)的犬与 VBP 合并感染之间的关联尚未得到研究。我们评估了患有 ClinL 和健康对照犬的 VBP 感染风险。
我们对来自塞浦路斯帕福斯的患有 ClinL(外周血中利什曼原虫 qPCR 和 ELISA 抗体阳性)和临床健康、理想的品种、性别和年龄匹配的对照犬(外周血中利什曼原虫 qPCR 和 ELISA 抗体阴性)进行了前瞻性病例对照研究。我们获得了人口统计学数据,所有犬均接受了 EDTA 血液提取 DNA 的 PCR 检测,用于检测血巴尔通体物种、埃立克体/无形体属、巴贝斯虫属和肝孢球虫属,并用 DNA 测序鉴定感染物种。我们使用逻辑回归分析和结构方程模型(SEM)评估 ClinL 病例和对照组之间 VBP 感染的风险。
从 50 只患有 ClinL 的入组犬中,24 只(48%)的犬检测到肝孢球虫属 DNA,14 只(28%)的犬检测到犬血巴尔通体属 DNA,6 只(12%)的犬检测到犬埃立克体属 DNA,2 只(4%)的犬检测到无形体属 DNA。在 92 只入组的对照犬中,41 只(45%)的犬检测到肝孢球虫属 DNA,18 只(20%)的犬检测到犬血巴尔通体属 DNA,1 只(1%)的犬检测到犬埃立克体属 DNA,3 只(3%)的犬检测到无形体属 DNA。未在任何犬中检测到巴贝斯虫属或“候选犬血巴尔通体”DNA。ClinL 组与对照组在年龄、性别、品种、生活方式和使用寄生虫预防措施方面无统计学差异。多变量逻辑回归分析显示,与对照组相比,ClinL 与犬埃立克体属感染之间存在显著关联(OR=12.4,95%CI:1.5-106.0,P=0.022)。结构方程模型进一步证实,年轻的犬更容易感染肝孢球虫属和犬血巴尔通体属,感染肝孢球虫属的犬更容易同时感染犬血巴尔通体属。
与临床健康犬相比,患有 ClinL 的犬更易合并感染犬埃立克体属。我们建议对诊断为 ClinL 的犬使用 PCR 检测进行犬埃立克体属合并感染检测。